AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results

Author's Avatar
Nov 07, 2019
Article's Main Image

Exceeded 125 REMS-certified facilities two months ahead of year-end goal

105 formulary approvals through October 31

$80.4 million of cash and short-term investments at September 30, 2019

PR Newswire